CN Patent
CN113214177B — 一种拉莫三嗪水合物的晶体形式、其制备方法及包含其的组合物
Assigned to Shanghai Aokeda Pharmaceutical Technology Co ltd · Expires 2022-05-03 · 4y expired
What this patent protects
本发明涉及一种拉莫三嗪水合物的晶体形式、其制备方法及包含其的组合物,具体涉及拉莫三嗪水合物形式A、其制备方法及包含拉莫三嗪水合物形式A的组合物。
USPTO Abstract
本发明涉及一种拉莫三嗪水合物的晶体形式、其制备方法及包含其的组合物,具体涉及拉莫三嗪水合物形式A、其制备方法及包含拉莫三嗪水合物形式A的组合物。
Drugs covered by this patent
- Lamictal (lamotrigine) · GSK
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.